Prostate News Archive
10-Feb-2007
Iris Files for FDA Prostate Test OK (AP via Yahoo! Finance)
Medical test company Iris International Inc. said Wednesday that its Iris Molecular Diagnostics unit filed for Food and Drug Administration clearance for a more sensitive prostate cancer test. Cancer cure from desert (Gulf News)
Dubai: Camels at a research centre in Dubai are playing a vital role in developing new ways of diagnosing and treating prostate cancer. QLT, Sanofi to Pay TAP $157.5 Million to Settle Suit (Update1) (Bloomberg.com)
Feb. 9 (Bloomberg) -- QLT Inc., a Canadian drugmaker, and Sanofi-Aventis SA agreed to pay a total of $157.5 million to end a patent suit so they can continue to sell the prostate cancer drug Eligard. Biomarker measures severity of prostate disease (Reuters via Yahoo! News)
Men with severe symptoms of prostate enlargement, so-called benign prostatic hyperplasia or BPH, have low blood levels of a protein dubbed JM-27, according to a new report.
Back to Prostate News Archive
